Expand ACON Menu
ACON MENU

ACON Latest Press Releases

-- June 10, 2026 --

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub Globe Newswire 7:00 AM

-- June 9, 2026 --

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform Globe Newswire 7:00 AM

-- June 8, 2026 --

Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal Globe Newswire 7:05 AM
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting Globe Newswire 7:00 AM

-- June 3, 2026 --

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation Globe Newswire 6:00 AM

-- June 1, 2026 --

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study Globe Newswire 6:00 AM

-- May 28, 2026 --

Aclarion, Inc. Comments on Echo Lake Capital's Letter and Unsolicited Proposal Globe Newswire 2:49 PM
Echo Lake Capital Offers To Acquire Aclarion Inc. ACCESS Newswire 8:00 AM

-- May 7, 2026 --

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment Globe Newswire 6:00 AM

-- May 6, 2026 --

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S. Globe Newswire 6:00 AM

-- May 5, 2026 --

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine Globe Newswire 6:00 AM

-- April 30, 2026 --

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption Globe Newswire 6:00 AM

-- April 28, 2026 --

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan Globe Newswire 6:00 AM

-- April 22, 2026 --

Aclarion Announces $2.5 Million Stock Repurchase Plan Globe Newswire 8:30 AM

-- April 16, 2026 --

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain Globe Newswire 6:47 AM

-- April 14, 2026 --

Aclarion Receives Pinnacle Award for AI Innovation Globe Newswire 8:00 AM

-- April 8, 2026 --

Aclarion Announces Agreement with Weill Cornell Medicine Globe Newswire 8:00 AM

-- April 7, 2026 --

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video Globe Newswire 8:00 AM

-- March 24, 2026 --

Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. ACCESS Newswire 8:00 AM

-- March 19, 2026 --

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan Globe Newswire 9:25 AM
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts Globe Newswire 6:00 AM

-- March 17, 2026 --

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet Globe Newswire 6:00 AM

-- March 12, 2026 --

Aclarion CEO Brent Ness to Attend LSI USA 2026 Globe Newswire 6:00 AM

-- February 5, 2026 --

Aclarion Publishes 2026 Shareholder Letter from the Chairman Globe Newswire 6:00 AM

-- February 3, 2026 --

Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes